Back to medications
Medication monograph

palbociclib

Cyclin-Dependent Kinase InhibitorsAntineoplastic AgentsKinase Inhibitor

Clinical reference

Product monograph

IBRANCE- palbociclib capsule

IBRANCE- palbociclib tablet, film coated

Brands & formulations

Family members

IBRANCE

Marketed
75 MGORALTABLET[ "palbociclib" ]
Product monograph

IBRANCE

Marketed
100 MGORALTABLET[ "palbociclib" ]
Product monograph

IBRANCE

Marketed
125 MGORALTABLET[ "palbociclib" ]
Product monograph

TARO-PALBOCICLIB

Marketed
75 MGORALTABLET[ "palbociclib" ]
Product monograph

TARO-PALBOCICLIB

Marketed
100 MGORALTABLET[ "palbociclib" ]
Product monograph

TARO-PALBOCICLIB

Marketed
125 MGORALTABLET[ "palbociclib" ]
Product monograph

PMS-PALBOCICLIB

Marketed
75 MGORALTABLET[ "palbociclib" ]
Product monograph

PMS-PALBOCICLIB

Marketed
100 MGORALTABLET[ "palbociclib" ]
Product monograph

PMS-PALBOCICLIB

Marketed
125 MGORALTABLET[ "palbociclib" ]
Product monograph

Pricing

Price information

Ibrance Tablet

Pfizer · 75 mg

21: $11218.56

Ibrance Tablet (ON BACKORDER)

Pfizer · 100 mg

21: $11361.41

Ibrance Tablet (ON BACKORDER)

Pfizer · 125 mg

21: $11504.27

Classification

Chemical class
Cyclin-Dependent Kinase Inhibitors
Clinical class
Antineoplastic Agents
Banks class
Kinase Inhibitor